ZA200303293B - Oil-based lotions for paper products. - Google Patents
Oil-based lotions for paper products. Download PDFInfo
- Publication number
- ZA200303293B ZA200303293B ZA200303293A ZA200303293A ZA200303293B ZA 200303293 B ZA200303293 B ZA 200303293B ZA 200303293 A ZA200303293 A ZA 200303293A ZA 200303293 A ZA200303293 A ZA 200303293A ZA 200303293 B ZA200303293 B ZA 200303293B
- Authority
- ZA
- South Africa
- Prior art keywords
- weight
- lotion composition
- paper product
- paper
- oil
- Prior art date
Links
- 239000006210 lotion Substances 0.000 title claims description 146
- 239000000203 mixture Substances 0.000 claims description 145
- 230000003750 conditioning effect Effects 0.000 claims description 41
- 239000003921 oil Substances 0.000 claims description 40
- 239000003995 emulsifying agent Substances 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 30
- 239000001993 wax Substances 0.000 claims description 29
- 239000003795 chemical substances by application Substances 0.000 claims description 28
- 239000007787 solid Substances 0.000 claims description 27
- 238000001035 drying Methods 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 16
- 150000002191 fatty alcohols Chemical class 0.000 claims description 15
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 14
- 239000003906 humectant Substances 0.000 claims description 13
- 239000004599 antimicrobial Substances 0.000 claims description 11
- 235000011187 glycerol Nutrition 0.000 claims description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 8
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 8
- 229940075529 glyceryl stearate Drugs 0.000 claims description 8
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 8
- 229960000541 cetyl alcohol Drugs 0.000 claims description 7
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 6
- 239000004264 Petrolatum Substances 0.000 claims description 5
- 230000002745 absorbent Effects 0.000 claims description 5
- 239000002250 absorbent Substances 0.000 claims description 5
- 239000000835 fiber Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 229940066842 petrolatum Drugs 0.000 claims description 5
- 235000019271 petrolatum Nutrition 0.000 claims description 5
- 229920001296 polysiloxane Polymers 0.000 claims description 5
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 5
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 4
- 229960000735 docosanol Drugs 0.000 claims description 4
- 239000012169 petroleum derived wax Substances 0.000 claims description 4
- 235000019381 petroleum wax Nutrition 0.000 claims description 4
- 229940012831 stearyl alcohol Drugs 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 77
- 239000004615 ingredient Substances 0.000 description 36
- 235000019198 oils Nutrition 0.000 description 26
- -1 soy sterol Substances 0.000 description 14
- 230000008591 skin barrier function Effects 0.000 description 10
- 239000003755 preservative agent Substances 0.000 description 8
- 239000000344 soap Substances 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 5
- 230000037067 skin hydration Effects 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- 102100028701 General vesicular transport factor p115 Human genes 0.000 description 4
- 101000767151 Homo sapiens General vesicular transport factor p115 Proteins 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000002947 alkylene group Chemical group 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229940126534 drug product Drugs 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000003094 microcapsule Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000005808 skin problem Effects 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 2
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 2
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 2
- FOLJTMYCYXSPFQ-CJKAUBRRSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-(octadecanoyloxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O[C@@H]1O[C@@]1(COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOLJTMYCYXSPFQ-CJKAUBRRSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940081620 ceteth-2 Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 229960001083 diazolidinylurea Drugs 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 229940074047 glyceryl cocoate Drugs 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 229940074046 glyceryl laurate Drugs 0.000 description 2
- 229940100608 glycol distearate Drugs 0.000 description 2
- 229940100242 glycol stearate Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002265 sensory receptor cell Anatomy 0.000 description 2
- 102000027509 sensory receptors Human genes 0.000 description 2
- 108091008691 sensory receptors Proteins 0.000 description 2
- 230000037075 skin appearance Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- 239000001589 sorbitan tristearate Substances 0.000 description 2
- 235000011078 sorbitan tristearate Nutrition 0.000 description 2
- 229960004129 sorbitan tristearate Drugs 0.000 description 2
- 229940033331 soy sterol Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229940010735 steareth-12 Drugs 0.000 description 2
- 229940098760 steareth-2 Drugs 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- OQWIKYXFAZAALW-FMDYKLJDSA-N (2S)-2-amino-5-oxo-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoic acid Chemical compound N[C@@H](CCC(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(O)=O OQWIKYXFAZAALW-FMDYKLJDSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- UOFCAQWHTQFNHS-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCO UOFCAQWHTQFNHS-UHFFFAOYSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000004831 Hot glue Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- RZCHTMXTKQHYDT-UHFFFAOYSA-N N-Lactoyl ethanolamine Chemical compound CC(O)C(=O)NCCO RZCHTMXTKQHYDT-UHFFFAOYSA-N 0.000 description 1
- PVCJKHHOXFKFRP-UHFFFAOYSA-N N-acetylethanolamine Chemical compound CC(=O)NCCO PVCJKHHOXFKFRP-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002651 Polysorbate 85 Polymers 0.000 description 1
- 229920002197 Sodium polyaspartate Polymers 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- RBAKOBGXSDZSNK-UHFFFAOYSA-N [3-bis[3-[dimethyl-[3-(octadecanoylamino)propyl]azaniumyl]-2-hydroxypropoxy]phosphoryloxy-2-hydroxypropyl]-dimethyl-[3-(octadecanoylamino)propyl]azanium trichloride Chemical compound [Cl-].[Cl-].[Cl-].CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)COP(=O)(OCC(O)C[N+](C)(C)CCCNC(=O)CCCCCCCCCCCCCCCCC)OCC(O)C[N+](C)(C)CCCNC(=O)CCCCCCCCCCCCCCCCC RBAKOBGXSDZSNK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 229940073639 ceteareth-6 Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 229940124447 delivery agent Drugs 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940031766 diethanolamine cetyl phosphate Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940052296 esters of benzoic acid for local anesthesia Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940061515 laureth-4 Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 229940031722 methyl gluceth-20 Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- JPMIIZHYYWMHDT-UHFFFAOYSA-N octhilinone Chemical compound CCCCCCCCN1SC=CC1=O JPMIIZHYYWMHDT-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 229940096994 peg-10 glyceryl stearate Drugs 0.000 description 1
- 229940072880 peg-10 stearate Drugs 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 229940077414 peg-12 stearate Drugs 0.000 description 1
- 229940119517 peg-6 stearate Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229940100518 polyglyceryl-4 isostearate Drugs 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229940113171 polysorbate 85 Drugs 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- LMWHCJFWODXSMN-UHFFFAOYSA-M sodium;1-dodecoxydodecane;octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCOCCCCCCCCCCCC LMWHCJFWODXSMN-UHFFFAOYSA-M 0.000 description 1
- 239000011122 softwood Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000002993 sponge (artificial) Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 229940100458 steareth-21 Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical class CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Paper (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Description
OIL-BASED LOTIONS FOR PAPER PRODUCTS
Absorbent paper products, such as hand towels are commonly : used to absorb fluids applied to the skin of a user during hand washing. The paper products are designed to absorb fluids from the skin and leave the skin dry. However, the soap ingredients often used to cleanse a person's hands or skin can remove oils, lipids, and natural skin conditioners and moisturizers from the stratum corneum of the person, leaving the skin excessively dry and subject to various skin problems, such as erythema, scales, flakes, and fissures. In addition, many people commonly wash their hands in environments susceptible to various diseases caused by the spread or growth of microbes, such as bacteria and viruses.
As such, a need currently exists for a paper product that contains a formulation that can readily transfer to the user's skin to inhibit excessive dryness and other skin-related problems.
The present invention is directed to a paper product that can dry and condition the skin of a user. In accordance with one embodiment of the present invention, a lotion composition is applied to the paper product that contains a variety of components. Typically, the add-on level of the lotion composition is between about 1% to about 10% by weight of the paper product. The lotion composition can generally contain a variety of components. For instance, the lotion composition contains an oil component in an amount up to about 70% by weight of the lotion composition. The oil component can include a variety of different ingredients, such as oils, oil-soluble skin-conditioning agents, : 25 etc. For example, in some embodiments, petrolatum can be used as . an oil. Moreover, if desired, caprylic/capric triglyceride may be utilized as an oil-soluble skin conditioning agent.
In addition, the lotion composition also includes a solid component (i.e., a solid at or below about 25°C) in an amount up to
) 1 WO 02/41868 PCT/USO1/45521 about 60% by weight of the lotion composition. The solid component can include a number of different ingredients. For instance, in some i embodiments, the solid component can include one or more fatty alcohols, such as cetyl alcohol, stearyl alcohol, cetearyl alcohol, arachidyl alcohol, behenyl alcohol, or combinations thereof. Moreover, the solid component may also include one or more waxes, such as natural waxes, petroleum waxes, silicone waxes, synthetic waxes, or combinations thereof.
Besides the above-mentioned components, the lotion also includes an optional water-soluble skin conditioning component in an amount up to about 80% by weight of the lotion composition. In some embodiments, for example, the water-soluble skin conditioning component can include a humectant, such as glycerin. If desired, an optional emulsifier component can also be utilized in conjunction with the water-soluble skin conditioning component in an amount up to about 35% by weight of the lotion. In some embodiments, the emulsifier component can include one or more emulsifiers that have an
HLB number less than about 5. One example of such an emulsifier is glyceryl stearate.
In accordance with another embodiment of the present invention, a process for producing a paper product for drying and conditioning the skin of a user is disclosed. The process includes forming a fibrous web, through-drying the web to remove water therefrom, and thereafter treating the dried web with a lotion composition such that the lotion has an add-on level of between about 1% to about 10% by weight of said paper product. For example, in some embodiments, the lotion composition can be printed onto the : paper web. In other embodiments, the lotion composition can also be sprayed onto the paper web. ‘30 It should be noted that any given range presented herein is intended to include any and all lesser included ranges. For example, a range of from 45-90 would also include 50-90; 45-80; 46-89 and the hb WO 02/41868 PCT/US01/45521 like. Thus, the range of 95% to 99.999% also includes, for example, the ranges of 96% to 99.1%, 96.3% to 99.7%, and 99.91 to 99.999%.
E Other features and aspects of the present invention are . discussed in greater detail below.
Detailed Description of Representative Embodiments
Reference now will be made in detail to various embodiments of the invention, one or more examples of which are set forth below.
Each example is provided by way of explanation of the invention, not limitation of the invention. In fact, it will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the scope or spirit of the invention. For instance, features illustrated or described as part of one embodiment, can be used on another embodiment to yield a still further embodiment. Thus, it is intended that the present invention cover such modifications and variations as come within the scope of the appended claims and their equivalents.
In general, the present invention is directed to a paper product that contains a lotion useful for treating a person’s skin. In particular, . the lotion contains an oil component and a solid component, an optional water-soluble skin conditioning component, an optional emulsifier component, and other various ingredients, such as other skin-conditioning agents, anti-microbial agents, etc. It has been discovered that the particular selection and amount of ingredients utilized in the lotion of the present invention can provide a synergistic effect when applied to a paper product. Moreover, it has also been discovered that the lotion of the present invention can be applied at relatively low add-on levels to a paper product such that the resulting * paper product can remain absorbent. As a result, the paper product of the present invention can dry a person’s skin after washing, while simultaneously imparting certain benefits to the skin, such as inhibiting microbial growth, skin disease, skin dryness, etc.
Paper products made in accordance with the present invention can include various types of products, such as towels, wipes, napkins, facial and bath tissue, and the like. The paper product can generally
E be produced from paper webs having one or multiple layers. \ Moreover, depending on the desired characteristics, the paper product can contain one or multiple plies where each ply can contain one or : more layers. The basis weight of the paper products can vary dependent on the particular application. In some embodiments, for example, the paper product can have a basis weight from about 1 to about 50 pounds per 2,880 square feet (i.e., ream), and in some embodiments, between about 5 to about 45 pounds per square ream.
For instance, paper towels can sometimes be formed to have a basis weight of from about 10 to about 45 pounds per ream, and in some embodiments, between about 20 to about 30 pounds per ream.
As stated above, the paper product of the present invention is applied with a lotion that contains a variety of components. For example, the lotion contains an oil component that contains one or more oils and/or oil-soluble ingredients, such as oil-soluble skin conditioning agents, etc. The amount of the oil component in the composition can generally vary. For example, in some embodiments, the amount of the oil component can be up to 70% by weight of the composition, in some embodiments between about 20% to about 60% by weight of the composition, and in some embodiments, between about 30% about 50% by weight of the composition.
Some oils that can be used in the present invention include, but are not limited to, petroleum or mineral oils, such as petrolatum; animal oils, such as mink oil and lanolin oil; plant oils, such as soy sterol, sunflower oil, and avocado oil; and silicone oils, such as alkyl methyl ’ silicones. For instance, in one embodiment, the use of petrolatum, sunflower seed oil, and/or soy sterol as oils has been determined to be particularly effective in the present invention. Moreover, the amount of oil utilized can be up to 70% by weight of the composition, and in some embodiments between about 10% to about 60% by weight of the
’ ¢ WO 02/41868 oo PCT/USO1/45521 composition.
Moreover, as stated above, oil-soluble skin conditioning agents, can also be utilized in some embodiments. A skin conditioning agent , generally refers to any material that can enhance certain properties of 5 the skin, such as by moisturizing the skin, softening the skin, protecting the skin, and the like. For example, skin conditioning agents can further moisturize a person's skin to inhibit excessive dryness and various related skin diseases. The amount of the oil-soluble skin conditioning agents utilized can be up to 15% by weight of the composition, and in some embodiments between about 1% to about 10% by weight of the composition.
Some suitable oil-soluble skin conditioning agents that can be used include, but are not limited to, capric acid, caproic acid, caprylic acid, caprylic/capric mixed acids, caprylic/capric triglyceride (e.g.
Crodamol GTCC sold by Croda, Inc.), cholesterol, lauric acid, magnesium stearate, myristic acid, oleic acid, palmitic acid, pentaerythritol, sorbitol, stearic acid, stearols (vegetable), methyl gluceth 20 benzoate, linear primary alkyl esters of benzoic acid, such as C,,-C,; alkyl benzoate (e.g., Finsolv® TN sold by Finetex, Inc.), ethoxylated cetyl stearyl alcohol, Finsolv® SLB 101 or SLB 201 (sold by Finitex Corp.), etc. For instance, one particularly effective oil- soluble skin conditioning agent has been determined to be caprylic/capric triglyceride.
The use of an oil component, such as described above, can provide a number of benefits to the lotion composition formed therefrom. For instance, the ingredients of the oil component can act as moisturizing agents when applied to the skin of a user. In particular, ‘ the ingredients of the oil component can, in some cases, enhance the ability of a user's skin to retain water even after using the paper product. By retaining water, a user's skin will be less prone to becoming excessively dry, as well as being inhibited from developing certain skin problems, such as erythema. Moreover, the ingredients of the oil component can also help to maintain the soft, smooth, and pliable appearance of the skin by remaining on the skin surface or in the stratum corneum to act as a lubricant, to reduce flaking, and to improve the skin's appearance.
In addition to an oil component, the lotion of the present invention can also contain a variety of other materials. For example, as stated above, the lotion of the present invention also typically contains a solid component that includes one or more ingredients that are a solid at or below about 25°C. For instance, some solid ingredients that can be utilized in the present invention include, but are not limited to, fatty alcohols, waxes, and the like. In general, the amount of the solid component can vary depending on the amount of the oil component utilized. For instance, in some embodiments, the amount of the solid component in the composition can be up to about 60% by weight of the composition, in some embodiments between about 10% to about 50% by weight of the composition, and in some embodiments, between about 15% to about 40% by weight of the composition. .
For example, some suitable fatty alcohols that can be used in the solid component include, but are not limited to, alcohols having a carbon chain length of C,, - C,,, including, for example, cetyi alcohol, stearyl alcohol, cetearyl alcohol (which is a mixture of cetyl alcohol and stearyl alcohols), arachidyl alcohol, and behenyl alcohol. Other suitable fatty alcohols are described in U.S. Patent Nos. 5,830,487 to
Klofta, et al. and 5,871,763 to Luu, et al., which are incorporated herein in their entirety by reference thereto for all purposes. The fatty alcohol ingredients can generally be present in various amounts, such as up to . about 50% by weight of the composition, in some embodiments between about 5% to about 40% by weight of the composition, and in some embodiments, between about 10% to about 30% by weight of the composition.
In addition, as noted above, the solid component can also
4 WO 02/41868 PCT/USO1/453521 include a variety of wax ingredients. For instance, some suitable waxes include, but are not limited to, natural waxes, such as beeswax ’ and carnauba wax; petroleum waxes, such as paraffin and ceresine way; silicone waxes, such as alkyl methyl siloxanes; or synthetic waxes, such as synthetic beeswax and synthetic sperm wax. The wax ingredients can generally be present within the composition in various amounts. For example, the wax ingredients may be present in an amount up to about 20% by weight of the composition, in some embodiments, between about 1% to about 15% by weight of the composition, and in some embodiments, between about 5% to about 10% by weight of the composition.
The solid component of the lotion can, in some embodiments, inhibit the ingredients of the oil component from substantially migrating into the interior of the paper when deposited onto the surface of the paper product. Thus, compared to paper products treated with some types of liquid formulations, a greater percentage of the resulting lotion of the present invention is retained on the surface of the paper product where it can contact and transfer to the user's skin to provide various benefits. Moreover, in certain instances, the ingredients of the solid component can also impart a soothing feel to the skin of a user.
Additionally, a lower add-on level can be used to deliver the same benefits at a lower cost because of the efficient placement of the composition substantially at the surface of the product.
For example, the inventors of the present invention have discovered that the combination of fatty alcohols and waxes may be particularly useful for helping retain the lotion on the surface of the paper product such that it can be more readily transferred to the skin of ‘ a user. For instance, in one embodiment, cetyl alcohol and/or stearyl alcohol can be utilized in conjunction with one or more waxes, such as "30 ceresin wax. For example, in this embodiment, the cetyl alcohol can be present in an amount up to about 30% by weight of the lotion, and particularly between about 5% to about 15% by weight of the lotion,
while the stearyl alcohol can be present in an amount up to about 20% by weight of the lotion, and particularly, between about 5% to about 15% by weight of the lotion. Moreover, the wax ingredient(s) can be present, in this embodiment, in an amount between about 5% to about 3) 10% by weight of the composition.
Besides the above-mentioned components, a lotion of the present invention can also include an optional water-soluble skin conditioning component that contains one or more water-soluble skin conditioning agents. The term "water-soluble" refers to a compound that has a hydrophilic-lipophilic balance (HLB) number of 7 or greater.
The HLB index is well known in the art and is a scale that measures the balance between the hydrophilic and lipophilic solution tendencies of a compound. The HLB scale ranges from 1 to approximately 100, with the lower numbers representing highly lipophilic tendencies and the higher numbers representing highly hydrophilic tendencies.
In some embodiments, the amount of the water-soluble skin conditioning component can be up to about 80% by weight of the lotion composition, in some embodiments up to about 60% by weight of the composition, and in some embodiments, between about 10% to about 40% by weight of the composition.
For example, in one embodiment, the water-soluble skin conditioning component can include a humectant (i.e., a compound that has an affinity for water). A humectant can generally provide a number of benefits to a lotion of the present invention. For example, as stated above, a lotion applied to a paper product can be transferred to a person's hand after use. Because the lotion contains a humectant, which has an affinity for water, it can further enhance the ‘ retention of moisture on the person’s skin and inhibit transepidermal water loss. The amount of humectant utilized in the lotion composition can vary. For example, in some embodiments, the amount of humectant can be up to about 35% by weight of the lotion composition, in some embodiments up to about 20% by weight of the composition,
w WO 02/41868 PCT/USO1/45521 and in some embodiments, between about 5% to about 20% by weight of the composition.
Some examples of suitable water-soluble humectants that can be used in the present invention include, but are not limited to, glycerin; ethoxylated glycerins, such as POE-26 glycerin, POE-7 glycerin, sorbitol, 1,2,6-hexanetriol sorbitol, and hydroxypropyl sorbitol; phosphinic carboxylic acid (PCA) and salts thereof, such as sodium
PCA; alpha hydroxy acids and salts thereof, such as lactic acid, sodium lactate, and glycolic acid; glucose derivatives, such as glucose glutamate; polyalkylene glycols and alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol, 1,3-butylene glycol, triethylene glycol, and dipropylene glycol; and other water-soluble humectants, such as maltodextrin, maltitol, mannitol, zylitol, sodium polyaspartate, ethoxylated castor oil, various humectants available from Lipo Chemicals (e.g., acetamide MEA, ethoxylated glycerin, lactamide MEA, etc.), and the like. For instance, the inventors of the present invention have discovered that glycerin may be particularly useful in moisturizing the skin of a user and protecting it from excessive drying and other problems with the skin. For example, in some embodiments, glycerin can utilized in an amount up to about 35% by weight of the lotion composition, in some embodiments up to about 20% by weight of the composition, and in some embodiments, between about 10% to about 20% by weight of the composition.
Moreover, besides the skin conditioning agents mentioned above, other skin conditioning agents can also be utilized in the lotion composition. For instance, some skin conditioning agents that may be suitable for use in the present invention include, but are not limited to, dimethicone, phospholipid SV (i.e., stearamidopropyl PG-dimonium chloride phosphate and cetyl alcohol), etc. Still other suitable skin conditioning agents are described in U.S. Patent No. 4,559,157 to
Smith et al., 4,690,821 to Smith et al., 5,830,487 to Klofta, et al., and
5,871,763 to Luu, et al., which are incorporated herein in their entirety by reference thereto for all purposes. It should also be understood that any of the ingredients mentioned above or below (e.g., oils, fatty alcohols, emulsifiers etc.) and/or other ingredients can also act as skin conditioning agents as well.
Besides the above-mentioned components, the lotion composition can also include an optional emulsifier component that contains one or more emulsifiers. Although not required in all instances, an emulsifier can help stabilize certain ingredients within the lotion. When utilized, the emulsifier component can generally be present in an amount up to about 35% by weight of the composition, in some embodiments between about 1% to about 30% by weight of the composition, and in some embodiments, between about 5% to about 25% by weight of the composition.
Some suitable emulsifiers that can be used in the present invention include, but are not limited to, alkylene oxide esters of fatty acids, alkylene oxide diesters of fatty acids, alkylene oxide ethers of fatty acids, etc. Some examples of such emulsifiers include, but are not limited to, ceteth-2, ceteth-6, ceteth-10, ceteth-12, ceteareth-6, ceteareth-10, ceteareth-12, ceteareth-20, steareth-2, steareth-6, steareth-10, steareth-12, steareth-12, steareth-20, steareth-21, PEG-6 stearate, PEG-10 stearate, PEG-100 stearate, PEG-12 stearate, PEG- 10 glyceryl stearate, PEG-20 glyceryl stearate, PEG-80 glyceryl tallowate, PEG-200 glyceryl tallowate, PEG-30 glyceryl cocoate, PEG- 80 glyceryl cocoate, PEG-8 dilaurate, PEG-10 distearate, glycol stearate, propylene glycol stearate, glycol distearate, glyceryl laurate, glyceryl oleate, and mixtures thereof. : Still other suitable emulsifiers can include laureth-4, polyethylene glycol 20 sorbitan monolaurate (Polysorbate 20), polyethylene glycol 5 soya sterol, PPG-2 methyl glucose ether distearate, Polysorbate 80, cetyl phosphate, potassium cetyl phosphate, diethanolamine cetyl phosphate, Polysorbate 60,
polyoxyethylene 20 sorbitan trioleate (Polysorbate 85), sorbitan monolaurate, sorbitan tristearate, sorbitan stearate, sucrose distearate, ’ sorbitan oleate, polyoxyethylene 4 lauryl ether sodium stearate, polyglyceryl-4 isostearate, and mixtures thereof. Besides the emulsifiers mentioned above, still other types of emulsifiers can also be utilized. For instance, other suitable emulsifiers that can be utilized in accordance with the present invention are described in U.S. Patent
No. 6,001,377 to SaNogueira, Jr., et al., which is incorporated herein in its entirety by reference thereto for all purposes.
In one embodiment, it has been discovered that emulsifier(s) having a relatively low HLB number, such as less than about 5, can be used to stabilize one or more ingredients of the water-soluble skin conditioning component. Moreover, emulsifiers having a relatively low
HLB number can also enhance the ability of the lotion to absorb water during use to enhance the absorption characteristics of a paper product of the present invention. For instance, some examples of suitable emulsifiers that have a relatively low HLB number include, but are not limited to, glyceryl stearate, sucrose distearate, steareth-2, sorbitan stearate, glycol stearate, glycol distearate, propylene glycol stearate, ceteth-2, sorbitan tristearate, glyceryl laurate, glyceryl oleate, etc.
When utilized, emulsifier(s) having a relatively low HLB number can be present in various amounts, such as up to about 35% by weight of the composition, in some embodiments between about 1% to about 30% by weight of the composition, and in some embodiments, between about 5% to about 25% by weight of the composition. For example, the present inventors have discovered that glyceryl stearate . may be particularly useful as a relatively low HLB number emulsifier to : stabilize water-soluble ingredient(s), such as glycerin. In fact, it has
C30 also been discovered that glyceryl stearate can help moisturize the skin of a user. For instance, in one embodiment, glyceryl stearate can be utilized in an amount between about 10% to about 25% by weight of the composition.
Besides emulsifiers having a relatively low HLB number, it should also be understood that emulsifiers having a relatively high HLB number, such as above about 5, can used to stabilize certain water- soluble and/or water-insoluble ingredients contained within the lotion of the present invention.
As stated above, various other ingredients may also be utilized in the lotion composition of the present invention. For instance, in some embodiments, an antimicrobial agent (i.e., an additive that is capable of inhibiting the growth of viruses, bacteria, fungi, and other microbes) can be incorporated into the lotion composition to disinfect a user's skin and/or to inhibit the further spread of certain microbes.
Typically, an antimicrobial agent utilized in the present invention is biocompatible. The antimicrobial agent can be soluble in the ail components or can reside in the oil as a suspension. For example, some suitable antimicrobial agents that can be used in the present invention include, but are not limited to, chiorohexidine gluconate; parachlorometaxylenol (PCMX); benzylthoneium chloride; chitosan, such as chitosan pyrrolidone carboxylate; 2,4,4'-trichloro-2'- hydroxydiphenyl ether (triclosan), etc. Other suitable antimicrobial agents are described in U.S. Patent Nos. 5,871,763 to Luu, et al., 5,334,388 to Hoang, et al., and 5,686,089 to Mitra, et al., which are incorporated herein in their entirety by reference thereto for all purposes.
The amount of an antimicrobial agent(s) utilized in the lotion composition of the present invention can generally vary. For example, in some embodiments, the amount of the antimicrobial agent(s) can be ‘ up to about 20% by weight of the composition, in some embodiments up to about 10% by weight of the composition, and in some embodiments, between about 0.01% to about 5% by weight of the composition.
Furthermore, in some embodiments, the lotion can also contain one or more preservatives. The preservative(s) can inhibit the growth of certain microbes on the paper product before and/or after use.
Moreover, when the lotion composition is transferred to the skin of a user, the preservative(s) can further inhibit the growth of microbes thereon. The amount of the preservative(s) utilized in the lotion composition of the present invention can generally vary. For example, in some embodiments, the amount of the preservative(s) can be up to about 5% by weight of the composition, in some embodiments up to about 3% by weight of the composition, and in some embodiments, between about 0.1% to about 2% by weight of the composition.
Some suitable preservatives that can be used in the present Co invention include, but are not limited to, Mackstat H 66 (available from
Mcintyre Group, Chicago, IL), DMDM hydantoin (e.g., Glydant Plus™,
Lonza, Inc., Fair Lawn, NJ), iodopropynyl butylcarbonate, Kathon (Rohm and Hass, Philadelphia, PA), methylparaben, propylparaben, 2- bromo-2-nitropropane-1,3-diol, benzoic acid, amidazolidiny! urea, diazolidinyl urea, and the like. Moreover, in one particular embodiment, a preservative obtained under the name “Phenonip” from
NIPA Hardwick can be utilized. Other suitable preservatives includes those sold by Sutton Labs, such as “Germall 115" (amidazolidinyl urea), “Germall II” (diazolidinyl urea), and “Germall Plus” (diazolidiny! urea and iodopropynyl butylcarbonate).
In order to better enhance the benefits to consumers, other ingredients can also be used. For instance, some classes of ingredients that can be used include, but are not limited to: antiacne actives (a drug product used to reduce the number of acne blemishes, acne pimples, blackheads, and whiteheads); antifoaming agents : (reduce the tendency of foaming during processing); antiseptic actives; antioxidants (product integrity); astringents--cosmetic (induce a tightening or tingling sensation on skin); astringents--drug (a drug product which checks oozing, discharge, or bleeding when applied to skin or mucous membrane and works by coagulating protein);
biological additives (enhance the performance or consumer appeal of the product); colorants (impart color to the product); deodorants (reduce or eliminate unpleasant odor and protect against the formation of malodor on body surfaces); external analgesics (a topically applied drug that has a topical analgesic, anesthetic, or antipruritic effect by depressing cutaneous sensory receptors, of that has a topical counterirritant effect by stimulating cutaneous sensory receptors); film formers (to hold active ingredients on the skin by producing a continuous film on skin upon drying); fragrances (consumer appeal); opacifiers (reduce the clarity or transparent appearance of the . product); skin exfoliating agents (ingredients that increase the rate of skin cell turnover such as alpha hydroxy acids and beta hydroxyacids); skin protectants (a drug product which protects injured or exposed skin or mucous membrane surface from harmful or annoying stimuli); sunscreens (ingredients that absorb at least 85 percent of the light in the UV range at wavelengths from 290 to 320 nanometers, but transmit
UV light at wavelengths longer than 320 nanometers); and surfactants (as cleansing agents, emulsifying agents, solubilizing agents, and/or suspending agents). For instance, in one embodiment, Aloe Vera powder can be utilized in an amount between about 0.0005% to about 0.005% by weight of the lotion composition.
Although various ingredients have been separately described herein, it should be understood that one ingredient may completely or partially accomplish the function of more than ingredient. For example, an oil utilized in the lotion of the present invention may also act as a skin conditioning agent.
In addition, in some embodiments, the lotion composition of the ' present invention is also anhydrous, i.e., generally free of water. By minimizing the amount of water, the resulting composition can sometimes be more easily retained on the surface of the paper product for transfer to the skin of a user. Moreover, in some instances, the utilization of lower amounts of water can inhibit the growth of various types of microbes. However, it should be understood that minor amounts of water may be present in the composition. In some embodiments, for example, the lotion composition contains water in an amount less than about 5% by weight of the paper product, in some embodiments less than about 1% by weight of the paper product, and in some embodiments, less than about 0.5% by weight of the paper product.
Once formed, the lotion composition described above can then be applied to the paper product. The paper product may be formed from any papermaking process known in the art. For example, a papermaking process of the present invention can utilize creping, embossing, wet-pressing, double creping, calendering, as well as other known steps in forming the paper web. One particular embodiment of the present invention utilizes a non-compressive drying technique, such as uncreped through-drying, to form the paper product. In some instances, an uncreped through-dried paper product may have good absorbency and wet-resiliency characteristics. Some examples of uncreped through-drying techniques are disclosed in U.S. Patent Nos. 5,048,589 to Cook, et al.; 5,399,412 to Sudall, et al.; 5,510,001 to
Hermans, et al.; 5,591,309 to Rugowski, et al.; and 6,017,417 to
Wendt, et al., which are incorporated herein in their entirety by reference thereto for all purposes.
For example, uncreped through-drying generally involves the steps of: (1) forming a furnish of cellulosic fibers, water, and optionally, other additives, such as debonders and wet-strength agents; (2) depositing the furnish on a traveling foraminous belt, thereby forming a fibrous web on top of the traveling foraminous belt; (3) subjecting the fibrous web to through-drying to remove the water from the fibrous web; and (4) removing the dried fibrous web from the traveling foraminous belt.
In some embodiments, once dried, the lotion composition described above can then be applied. In general, the lotion composition of the present invention can be applied to the paper product using a variety of methods. For instance, in one embodiment, the composition can be applied to the surface of the paper product using rotogravure printing, either direct or indirect (offset). Rotogravure printing can sometimes offer better control of the distribution and transfer rate of the composition onto the paper product. In addition, other application methods, such as flexographic printing, spraying (e.g., WEKO), hot melt adhesive spraying (e.g., Nordson), blade, saturant, coating, droplet throw, and foam applications, can be used.
Further, the lotion composition can be applied to one or both outer surfaces of the product after the product has been dried. When utilizing a multi-ply paper product, the lotion composition can be applied after the plies are brought together or prior to bringing the plies together. The individual plies can be layered or blended (homogeneous), creped or uncreped, through-dried or wet-pressed. In one embodiment, for example, the paper product is an uncreped through-dried paper product.
Other methods of applying the lotion to a paper product can also be utilized. For example, some ingredients of the lotion can be first entrapped within a porous delivery vehicle before being applied to the paper product such that the ingredients can be controllably released during drying and after the lotion is transferred to a user's skin. For instance, some delivery vehicles that can be used include, but are not limited to, microsponges, microcapsules, cyclodextrins and their derivatives, liposomes, polymeric sponges, and spray-dried starch. For instance, in some embodiments, the lotion composition may contain microcapsules in an amount of up to about 25% by weight of the lotion, in some embodiments up to about 10% by weight of the lotion, and in some embodiments, between about 0.2% to about 5% by weight of the lotion.
For instance, some examples of "microsponges” are described in U.S. Pat. No. 4,690,825 to Won, which is incorporated herein in its entirety by reference thereto for all purposes. Another delivery vehicle that may be useful is a sponge-like material, such as POLY-PORE®
L200. Moreover, one example of a microcapsule that may be suitable for use in the present invention is POLY-PORE® E200 (Chemdal
Corp., Arlington Heights, IL), which is a delivery agent having soft, hollow spheres that can contain an additive at over 10 times the weight of the delivery vehicle.
The add-on level of the lotion can generally vary depending on the desired effect of the composition on the product attributes and the specific composition. As used herein, the term “add-on level” refers to the weight of a paper product treated with the lotion composition subtracted by the weight of the paper product prior to treatment, wherein this calculated weight is divided by the weight of the treated paper product and then multiplied by 100. For example, the add-on level of the composition can be from about 1 to about 10 weight percent, in some embodiments from about 1 to about 6 weight percent, in some embodiments, from about 1 to about 5 weight percent, and in some embodiments, from about 1 to about 3 weight percent, based on the weight of the paper product.
The present invention may be better understood with reference to the following examples.
EXAMPLE 1
The ability to form lotions for use on a paper product in accordance with the present invention was demonstrated. In particular, three lotions labeled A, B, and C were formed having the following characteristics:
Table 1: Components of the Lotion Compositions
Ingredient A (Wt.% of B (wt.% of C (wt. % of a el Feil ed neon [om [oo [ress [sumoerseasor [1020 [mor [ow
Soyse 10 [100 [ooo
Gyo Seorae [540 [200 [ooo
Coeanvie | reo [oo [ooo 0 [wwewss Jom [re Joe [poysopmess [2m [oo loo tawetna [ooo Joo [300
Sotan Oeste | 200 | 700 | 000
Gyoon [am [so [wo
IT ET
Coco 8.00
ER a
GycoryiOleate | 200 [200 [ooo
The lotion compositions were prepared by mixing all of the components at a temperature of about 75°C until melted.
EXAMPLE 2
The ability of a paper product to condition the skin of a user during drying was demonstrated. A lotion was first formed having the following composition:
Table 2: Components of the Lotion Composition ;
The lotion composition was prepared by mixing all of the components at a temperature of about 75°C until melted. Thereafter, the resulting lotion was manually applied with a hand operated printing roll to an uncreped through-dried hand towel that was formed in a manner such as described above such that the add-on level was 6% by weight of the hand towel. The towel was formed from recycled fibers in an amount of 50% by weight of the web and from Pictou northern softwood fibers in an amount of 50% by weight of the web.
The Pictou fibers were refined for 8 minutes using conventional refining techniques. The furnishes were then supplied to a machine chest and blended. A Kymene® 557H wet strength agent from Hercules, Inc. was also added to the machine chest in an amount of 20 pounds per ton. Further, a Witco C-6001 imidazoline-based softener was applied to the machine chest thereafter in an amount of 1.5 pounds per ton.
The fibrous furnish was then formed into a paper web and dried using a through-air dryer. The resulting hand towel had a basis weight of 25 pounds per ream.
After forming the hand towel, the properties of the treated hand towel were compared to an untreated hand towel using the following procedure. Initially, 14 nurses washed their hands four times with
IVORY® Bar Soap and dried them with the untreated towel that was folded. During each wash, the hands of the nurses were thoroughly washed and lathered for 15 seconds.
Thereafter, the subjects then washed their hands four additional times and dried them with the treated hand towel of the present invention. The number of towels used after the first and fourth washes was recorded. After a five minute waiting period, the nurses washed their hands four additional times. Finally, the nurses were asked to compare the overall hand feel and drying ability of each towel.
Table 3 reflects the percent of those tested who only used the corresponding number of towels to dry their hands after the first and fourth washes for the untreated sample.
Table 3: Towel Usage (untreated sample)
Number of Towels (%) First Wash (%) Fourth Wash
FS al ia hn Joo Joo
ER PR YR
I FE 7 RE TR
Table 4 reflects the percent of those tested who only used the corresponding number of towels to dry their hands after the first and fourth washes for the treated sample.
Table 4: Towel Usage (treated sample)
Number of Towels (%) First Wash (%) Fourth Wash al
SN PR ET SE NT
As illustrated from the Tables 3 and 4, the addition of the lotion composition onto a hand towel did not substantially affect the ability of the towel to dry a person's hands. For example, the percentage of the subjects that needed four towels to dry their hands for the first wash only increased from 7.0% to 14.0%.
In addition, various other attributes of the hands of the subjects after using the samples are also given below in Table 5.
Table 5: Hand Attributes
Attribute % Who % Who % Who : Preferred Preferred Perceived No
Untreated Treated Difference in
Towel Towel Samples :
Overall Hand 14.0 79.0 7.0 ill a
As indicated above, the hand towel of the present invention can impart a number of beneficial affects to the user of a skin when used.
Moreover, the ability of the lotion to affect the moisture and skin barrier properties of skin was also tested. In particular, nine subjects were first acclimated in a controlled room set at 70°F and 50% relative humidity for 20 minutes. Upon acclimation, each subject had four 63 cm? test sites outlined on their volar forearm using a standard template. A series of baseline measurements were then taken from each test site with a Skicon-200 Conductance Meter (measurement of skin hydration) and a DermaLab® Systems Instrument (measurement of skin barrier damage). With the Skicon Meter, five conductance readings were taken for each 63 cm” test site and averaged. With the
Dermal ab® Instrument, four readings per second were taken at each
Co test site and averaged.
The test sites were then washed with Ivory® Bar soap and dried with the appropriate hand towel (untreated and treated with the lotion of Table 2). To wash, the technician wet the site for 10 seconds, lathered for 30 seconds with Ivory® soap using a circular motion with the first two fingers, rinsed for 15 seconds or more if necessary until ~ site was completely free of soap. For wiping, each towel was folded ’ into quarters and then folded into eighths. The fest site was wiped using a downward motion with one side of the vertically held towel : turned over to wipe with other side. The technician started at the top of each site with hands adjacent to each other to make a downswing motion to assure that as much of the towel contacted the test site as possible. The site was wet with water (for 5 seconds) and the towel then turned to the next % area. Drying steps were repeated 3 more times, as described above, to ensure that the entire towel was used.
This procedure was repeated every fifteen minutes, four times per day, for four consecutive days. One hour after the final wash, measurements were taken using the Skicon-200 Conductance Meter and the Dermalab® Systems Instrument. A total of 4 untreated towels and 4 treated towels was used each day. On the fifth day, only baseline readings were taken. The Skicon results are shown below in
Table 6 and the DermaLab® results are shown in Table 7.
The data shown in Tables 6 and 7 represents the average percent change from the Day 1 base line, before washing each day (referred to as “b”) and after the final wash of a day (referred to as “a”), over the five-day time period for the untreated and treated towels. A decrease in SkiCon values from the baseline represents a decrease in skin hydration properties, while an increase in DermalLab® values from the baseline represents an increase in skin barrier damage.
Table 6: Skicon Results (Skin Hydration Properties)
Day1 | Day2 |Day2 |Day3 |Day3 |Day4 | Day4 | Day 5
TE Fl Pl Pel il Fl Pi Pe
Towel
Towel
As shown in Table 6, the towel! treated according to the present invention exhibited improved moisture conductance compared to the untreated towel. For instance, after five days, the untreated towel had 21% less moisture conductance than the initial baseline moisture conductance, while the treated towel remained the same.
Table 7: DermLab® Results (Skin Barrier Damage Properties) | Day1 {Day2 [Day2 |(Day3 |Day3 |Day4 |Day4 | Day5
TE Fl FF Fl Fl
Er oll dd
Towel
Towel
As shown in Table 7, the towel treated according to the present invention exhibited improved skin barrier properties compared to the untreated towel. For instance, after five days, the untreated towel had a 314% increase in skin barrier damage from the initial baseline reading, while the treated towel had an increase of only 211%.
EXAMPLE 3
The ability of a paper product to condition the skin of a user during drying was demonstrated. A lotion was first formed having the following composition:
Table 8: Components of the Lotion Composition *The microsponges encapsulated 75% of the dimethicone.
The lotion composition was prepared by mixing all of the components at a temperature of about 75°C until melted. Thereafter,
the resulting lotion was manually applied with a hand operated printing roll to an uncreped through-dried hand towel that was formed in a manner such as described above such that the add-on level was 6% by weight of the hand towel. The towel was formed as described in
Example 2.
After forming the hand towel, the properties of the hand towel of the present invention were compared to an untreated hand towel using the following procedure. Initially, 14 nurses washed their hands four times with IVORY® Bar Soap and dried them with the untreated towel that was folded. During each wash, the hands of the nurses were thoroughly washed and lathered for 15 seconds.
Thereafter, the subjects then washed their hands four additional times and dried them with the hand towel of the present invention. The number of towels used after the first and fourth washes was recorded.
After a five minute waiting period, the nurses washed their hands four additional times. Finally, the nurses were asked to compare the overall hand feel and drying ability of each towel.
Table 9 reflects the percent of those tested who only used the corresponding number of towels to dry their hands after the first and fourth washes for the untreated sample.
Table 9: Towel Usage (untreated sample)
Number of Towels (%) First Wash (%) Fourth Wash
Used + Joo Joo 4 Joo Joo
Table 10 reflects the percent of those tested who only used the corresponding number of towels to dry their hands after the first and fourth washes for the treated sample.
Table 10: Towel Usage (treated sample)
Used we me ;
PE ETE EY
As illustrated from the Tables 9 and 10, the addition of the lotion composition onto a hand towel did not substantially affect the ability of the towel to dry a person’s hands. For example, the percentage of the subjects that needed four towels to dry their hands for the fourth wash only increased from 0.0% to 3.0%.
In addition, various other attributes of the hands of the subjects after using the samples are also given below in Table 11.
Table 11: Hand Attributes
Attribute % Who % Who % Who
Preferred Preferred Perceived No
Untreated Treated Difference in
EEE
Smootwess [m0 [0 [oo 2
Overall Hand 29.0 71.0
Ell
As indicated above, the hand towel of the present invention can impart a number of beneficial affects to the user of a skin when used.
Moreover, the ability of the lotion to affect the moisture conductance of skin was also tested. In particular, an untreated towel and treated towel were tested for moisture conductance in the manner set forth in Example 2. The Skicon and DermLab® results are shown below in Tables 12 and 13. The data shown in Tables 12 and 13 represents the average percent change from the Day 1 base line, before washing each day (referred to as “b”) and after the final wash of a day (referred to as “a”), over the five-day time period for the untreated and treated towels. A decrease in SkiCon values from the baseline represents a decrease in skin hydration properties, while an increase in DermalLab® values from the baseline represents an increase in skin barrier damage.
Table 12: Skicon Results (Skin Hydration Properties)
Day1 |[Day2 |Day2 | Day3 |Day3 | Day4 | Day4 | Day 5
Tl Fl Fl Fe il Fel id
Towel ‘
Towel
As shown in Table 12, the towel treated according to the present invention exhibited improved moisture conductance compared to the untreated towel. For instance, after five days, the untreated towel had 21% less moisture conductance than the initial baseline moisture conductance, while the treated towel had only 3% less moisture conductance than the initial baseline moisture conductance.
Table 13: DermLab® Results (Skin Barrier Damage Properties)
Day1 {Day2 | Day2 } Day3 | Day3 | Day4 | Day4 {| Day 5
TF il Fl Fe Fl Fel
Untreated | 62% 62% 202% | 228% | 401% | 323% | 414% | 314%
Froese l
Towel
As shown in Table 13, the towel treated according to the present invention exhibited improved skin barrier properties compared to the untreated towel. For instance, after five days, the untreated towel had a 314% increase in skin barrier damage from the initial baseline reading, while the treated towel had an increase of only 183%.
Thus, as indicted from the representative examples above, a paper product of the present invention can provide numerous benefits 3) to a user. Specifically, it has been discovered that the particular selection and amount of ingredients utilized in the lotion of the present invention can provide a synergistic effect when applied to a paper product. For instance, the lotion applied to the paper product can help moisturize the skin of a user during use, as well as remaining on a user's hands for continued moisturizing affects. In some cases, the lotion can enhance the ability of a user's skin to retain water even after using the paper product. By retaining water, a user's skin can be prevented from becoming excessively dry, as well as being inhibited from developing certain skin problems, such as erythema. Moreover, the lotion can help to maintain the soft, smooth, and pliable appearance of the skin by its ability to remain on the skin surface or in the stratum corneum to act as a lubricant, to reduce flaking, and to improve the skin's appearance. In some instances, the lotion can even help disinfect the skin of a user to inhibit the growth and/or spreading of various microbes.
In addition, as a result of the lower lotion add-on level that is obtainable in accordance with the present invention, a paper product formed therewith can also retain the ability to dry a person’s skin.
Thus, for example, a person can initially wash his/her hands using conventional soap. Thereafter, the person can utilize a paper product of the present invention for drying the wetted skin.
While the invention has been described in detail with respect to the specific embodiments thereof, it will be appreciated that those skilled in the art, upon attaining an understanding of the foregoing, may readily conceive of alterations to, variations of, and equivalents to these embodiments. Accordingly, the scope of the present invention should be assessed as that of the appended claims and any equivalents thereto.
Units which are used in this specification and which are not in accordance with the metric system may be converted to the metric system with the aid of the following table: 1 pound = 4.536 x 107" kg 1 foot = 3.048 x 10" m 1°C = (°F-32)5/9
AMENDED SHEET — DATED 27 JULY 2004
Claims (51)
1. An absorbent paper product for drying and conditioning the skin of a user, said paper product having a basis weight between about 1 to about 50 pounds per ream, said paper product comprising: a paper web; and a lotion composition applied to said paper web at an add-on level between about 1% to about 10% by weight of said paper product, said lotion composition comprising: i) an oil component in an amount up to about 70% by weight of said lotion composition, said oil component comprising at least one oil and at least one oil-soluble skin conditioning agent; and ii) a solid component in an amount up to about 60% by weight of said lotion composition, said solid component comprising a material selected from the group consisting of fatty alcohols, waxes, and combinations thereof.
2. A paper product as defined in claim 1, wherein said lotion composition includes a water-soluble skin conditioning component in an amount up to about 80% by weight of said lotion composition.
3. A paper product as defined in claim 1 or claim 2, wherein said lotion composition includes an emulsifier component in an amount up to about 35% by weight of said lotion composition.
4. A paper product as defined in any one of claims 1 to 3, wherein said oil component comprises between about 30% to about 50% by weight of said lotion composition.
5. A paper product as defined in any one of claims 1 to 3, wherein said at [east one oil is present in an amount between about 10% to about 60% by weight of said lotion composition.
6. A paper product as defined in any one of claims 1 to 3, wherein said at least one oil includes petrolatum.
7. A paper product as defined in any one of claims 1 to 3, wherein said at least one oil-soluble skin conditioning agent is present in an amount between about 1% to about 10% by weight of said lotion composition. AMENDED SHEET - DATED 27 JULY 2004
8. A paper product as defined in any one of claims 1 to 3, wherein said at least one oil-soluble skin conditioning agent includes caprylic/capric triglyceride.
9. A paper product as defined in any one of claims 1 to 3, wherein said solid component comprises between about 15% to about 40% by weight of said lotion composition.
10. A paper product as defined in any one of claims 1 to 3, wherein said solid component comprises at least one fatty alcohol in an amount between about 10% to about 30% by weight of said lotion composition.
11. A paper product as defined in any one of claims 1 to 3, wherein said fatty alcohols include cetyl alcohol, stearyl alcohol, cetearyl alcohol, arachidyl alcohol, behenyl alcohol, or combinations thereof.
12. A paper product as defined in any one of claims 1 to 3, wherein said solid component comprises at least one wax in an amount between about 5% to about 10% by weight of said lotion composition.
13. A paper product as defined in any one of claims 1 to 3, wherein said wax includes natural waxes, petroleum waxes, silicone waxes, synthetic waxes, or combinations thereof.
14. A paper product as defined in either claim 2 or claim 3, wherein said water-soluble skin conditioning component comprises between about 10% to about 40% by weight of said lotion com position.
15. A paper product as defined in claim 14, wherein said water- soluble skin conditioning component includes a humectant.
16. A paper product as defined in claim 15, wherein said humectant includes glycerin.
17. A paper product as defined in claim 3, wherein said emulsifier component comprises between about 5% to about 25% by weight of said lotion composition.
18. A paper product as defined in claim 17, wherein said emulsifier component includes at least one emulsifier having an HLB number below about 5. AMENDED SHEET - DATED 27 JULY 2004
19. A paper product as defined in claim 18, wherein said at least one emulsifier comprises between about 5% to about 25% by weight of said lotion composition.
20. A paper product as defined in claim 18, wherein said at least one emulsifier includes glyceryl stearate.
21. A paper product as defined in any one of claims 1 to 3, wherein said add-on level of said lotion composition is between about 1% to about 6% by weight of said paper product.
22. A paper product as defined in any one of claims 1 to 3, wherein said add-on level of said lotion composition is between about 1% to about 3% by weight of said paper product.
23. A paper product as defined in any one of claims 1 to 3, wherein said lotion composition further comprises an antimicrobial agent.
24. A paper product as defined in any one of claims 1 to 3, wherein said paper product is a towel having a basis weight between about 10 to about 45 pounds per ream.
25. An absorbent paper towel for drying and conditioning the skin of a user, said towel having a basis weight from about 10 to about 45 pounds per ream, said towel comprising: a paper web; a lotion composition applied to said paper web such that the add-on level of said lotion is between about 1% to about 10% by weight of said paper towel, said lotion composition being generally free of water and comprising the following components: i) an oil component in an amount up to about 70% by weight of said lotion composition, said oil component including at least one oil in an amount between about 10% to about 60% by weight of said lotion composition and at least one oil-soluble skin conditioning agent in an amount between about 1% to about 10% by weight of said lotion composition; ii) a solid component in an amount up to about 80% by weight of said lotion composition, said solid component comprising at least one AMENDED SHEET — DATED 27 JULY 2004 fatty alcohol, said fatty alcohol comprising between about10% to about 30% by weight of said lotion composition; and iil) a water-soluble skin conditioning component in an amount up to about 80% by weight of said lotion composition, said water-soluble skin conditioning component including at least one humectant; and iv)an emulsifier component in an amount up to about 35% by weight of said lotion composition, said emulsifier component including at least one emulsifier having an HLB number less than about 5, said at least one emulsifier comprising between about 5% to about 25% by weight of said lotion composition.
26. A paper towel as defined in claim 25, wherein said solid component includes a wax.
27. A paper towel as defined in claim 25 or claim 26, wherein said at least one oil includes petrolatum.
28. A paper towel as defined in claim 25 or claim 26, wherein said at least one oil-soluble skin conditioning agent includes caprylic/capric triglyceride.
29. A paper towel as defined in claim 25 or claim 26, wherein said at least one fatty alcohol includes cetyl alcohol, stearyl alcohol, cetearyl alcohol, arachidyl alcohol, behenyl alcohol, or combinations thereof.
30. A paper towel as defined in claim 26, wherein said wax includes natural waxes, petroleum waxes, silicone waxes, synthetic waxes, or combinations thereof.
31. A paper towel as defined in claim 25 or claim 26, wherein said at least one humectant includes glycerin.
32. A paper towel as defined in claim 25 or claim 26, wherein said at least one emulsifier includes glyceryl stearate.
33. A paper towel as defined in claim 25 or claim 26, wherein said add-on level of said lotion composition is between about 1% to about 6% by weight of said paper product. AMENDED SHEET - DATED 27 JULY 2004
34. A paper towel as defined in claim 25 or claim 26, wherein said add-on level of said lotion composition is between about 1% to about 3% by weight of said paper product.
35. A paper towel as defined in claim 25 or claim 26, wherein said lotion composition further comprises an antimicrobial agent.
36. A method for forming a paper product for drying and conditioning the skin of a user, said method comprising: forming an absorbent paper web from at least one furnish containing fibers and water; through-drying said web to remove water therefrom: and thereafter, treating said dried web with a lotion composition such that said lotion has an add-on level of between about 1% to about 10% by weight of said paper product, said paper product having a basis weight between about 1 to about 50 pounds per ream,said lotion composition comprising: i) an oil component in an amount up to about 70% by weight of said lotion composition, said oil component comprising at least one oil and at least one oil-soluble skin conditioning agent; and ii) a solid component in an amount up to about 60% by weight of said lotion composition, said solid component comprising a material selected from the group consisting of fatty alcohols, waxes, and combinations thereof.
37. A method as defined in claim 36, wherein said lotion composition includes a water-soluble skin conditioning component in an amount up to about 80% by weight of said lotion composition.
38. A method as defined in claim 36 or claim 37, wherein said lotion composition includes an emulsifier component in an amount up to about 35% by weight of said lotion composition.
39. A method as defined in any one of claims 36 to 38, wherein said lotion composition is printed onto said paper web.
40. A method as defined in any one of claims 36 to 38, wherein said lotion composition is sprayed onto said paper web. AMENDED SHEET —- DATED 27 JULY 2004
41. A method as defined in any one of claims 36 to 38, wherein said at least one oil is present in an amount between about 10% to about 60% by weight of said lotion composition.
42. A method as defined in any one of claims 36 to 38, wherein said at least one oil-soluble skin conditioning agent is present in an amount between about 1% to about 10% by weight of said lotion composition.
43. A method as defined in any one of claims 36 to 38, wherein said solid component comprises at least one fatty alcohol in an amount between about 10% to about 30% by weight of said lotion composition.
44. A method as defined in any one of claims 36 to 38, wherein said solid component comprises at least one wax in an amount between about 5% to about 10% by weight of said lotion composition.
45. A method as defined in claim 37, wherein said water-soluble skin conditioning component comprises between about 10% to about 40% by weight of said lotion composition.
46. A method as defined in claim 38, wherein said emulsifier component includes at least one emulsifier having an HLB number below about 5.
47. A method as defined in claim 46, wherein said at least one emulsifier comprises between about 5% to about 25% by weight of said lotion composition.
48. A method as defined in any one of claims 36 to 38, wherein said add-on level of said lotion composition is between about 1% to about 6% by weight of said paper product.
49. A method as defined in any one of claims 36 to 38, wherein said add-on level of said lotion composition is between about 1% to about 3% by weight of said paper product.
50. A method as defined in any one of claims 36 to 38, wherein said lotion composition further comprises an antimicrobial agent.
51. A method as defined in any one of claims 36 to 38, wherein said paper product is a towel having a basis weight between about 10 to about 45 pounds per ream. - AMENDED SHEET —- DATED 27 JULY 2004
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71807000A | 2000-11-21 | 2000-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200303293B true ZA200303293B (en) | 2004-04-29 |
Family
ID=24884702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200303293A ZA200303293B (en) | 2000-11-21 | 2003-04-29 | Oil-based lotions for paper products. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1335703A2 (en) |
JP (1) | JP2004513961A (en) |
KR (1) | KR20030062348A (en) |
CN (1) | CN1476324A (en) |
AU (1) | AU2002228714A1 (en) |
BR (1) | BR0115555A (en) |
CA (1) | CA2427329A1 (en) |
MX (1) | MXPA03004418A (en) |
WO (1) | WO2002041868A2 (en) |
ZA (1) | ZA200303293B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4421831B2 (en) * | 2003-03-27 | 2010-02-24 | 株式会社コーセー | Oily cosmetics |
US20050058693A1 (en) * | 2003-09-11 | 2005-03-17 | Kimberly-Clark Worldwide, Inc. | Tissue products comprising a moisturizing and lubricating composition |
JP5363698B2 (en) * | 2005-09-30 | 2013-12-11 | 大王製紙株式会社 | Chemical tissue-containing tissue paper |
JP4287438B2 (en) | 2006-01-31 | 2009-07-01 | 大王製紙株式会社 | Thin paper containing chemicals |
JP6375677B2 (en) * | 2014-04-16 | 2018-08-22 | 日油株式会社 | Sanitary paper softener |
KR102077806B1 (en) | 2017-04-11 | 2020-02-14 | 반성연 | Absorbent cosmetic composition |
GB2586371A (en) * | 2018-02-28 | 2021-02-17 | Kimberly Clark Co | Patterned lotion tissue |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100392676B1 (en) * | 1997-09-05 | 2003-07-28 | 더 프록터 앤드 갬블 캄파니 | Cleansing and conditioning products for skin or hair with improved deposition of conditioning ingredients |
AU756691B2 (en) * | 1998-04-24 | 2003-01-23 | Procter & Gamble Company, The | Cleansing articles for skin and/or hair which also deposits skin care actives |
-
2001
- 2001-11-15 CN CNA018192661A patent/CN1476324A/en active Pending
- 2001-11-15 KR KR10-2003-7006785A patent/KR20030062348A/en not_active Application Discontinuation
- 2001-11-15 AU AU2002228714A patent/AU2002228714A1/en not_active Abandoned
- 2001-11-15 JP JP2002544047A patent/JP2004513961A/en active Pending
- 2001-11-15 CA CA002427329A patent/CA2427329A1/en not_active Abandoned
- 2001-11-15 EP EP01989836A patent/EP1335703A2/en not_active Withdrawn
- 2001-11-15 WO PCT/US2001/045521 patent/WO2002041868A2/en not_active Application Discontinuation
- 2001-11-15 MX MXPA03004418A patent/MXPA03004418A/en unknown
- 2001-11-15 BR BR0115555-5A patent/BR0115555A/en not_active IP Right Cessation
-
2003
- 2003-04-29 ZA ZA200303293A patent/ZA200303293B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1476324A (en) | 2004-02-18 |
WO2002041868A2 (en) | 2002-05-30 |
KR20030062348A (en) | 2003-07-23 |
AU2002228714A1 (en) | 2002-06-03 |
WO2002041868A3 (en) | 2003-03-13 |
EP1335703A2 (en) | 2003-08-20 |
JP2004513961A (en) | 2004-05-13 |
MXPA03004418A (en) | 2003-09-04 |
CA2427329A1 (en) | 2002-05-30 |
BR0115555A (en) | 2005-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1043942B1 (en) | Soft tissue achieved by applying a solid hydrophilic lotion | |
CA2427245C (en) | Paper products treated with oil-in-water emulsions | |
US5648083A (en) | Personal care compositions and wipe products containing the compositions | |
US5871763A (en) | Substrate treated with lotion | |
CA2427277C (en) | Water-soluble lotions for paper products | |
CA2306594C (en) | Lotionized tissue products containing a ph balance compound for the skin | |
AU2002232771A1 (en) | Paper products treated with oil-in-water emulsions | |
JP3450230B2 (en) | Fiber web product and method for producing the same | |
US20050136097A1 (en) | Soft paper-based products | |
ZA200303293B (en) | Oil-based lotions for paper products. | |
WO2000064409A1 (en) | Skin barrier enhancing absorbent tissues | |
MXPA00001603A (en) | Soft tissue achieved by applying a solid hydrophilic lotion |